Abstract:Most radiogenomics studies focused on identifying imaging phenotypes as a surrogate to mirror a pre-selected set of molecular tumor parameters in cancer patients, which may not fully characterize heterogeneous biological processes within the tumor region, thus compromising the power of radiogenomics to determine prognosis and guide treatment. In this study, we developed a radiogenomics framework to synergistically integrate CT radiomics signatures with gene profiles to predict 1-year early recurrence (ER) and overall survival (OS) in patients with esophageal cancer (EC) receiving concurrent chemoradiation (CRT). Forty-nine patients diagnosed with EC who were treated with CRT were included in this study. All patients received CT scan before therapy and 468 radiomics features were extracted from tumor regions using texture analysis. Related tumor samples obtained via endoscopic biopsy were also used for gene profiling (1046 genes) via exome sequencing technology. The Mann-Whitney test was applied to assess the differences of individual radiomics and genomics features between ER and non-ER groups. The 4-fold cross validation method and the least absolute shrinkage and selection operator (LASSO) regression were employed to select optimal features from both imaging and gene features. Radiomics and genomics signatures were then built separately based on selected features. The multivariable logistic regression was used to construct a radiogenomics model via integrating radiomics with genomics signatures. The utilities of the radiomics signature, genomics signature and radiogenomics model in predicting 1-year ER were evaluated by ROC method individually. The Kaplan-Meier and log-rank tests were also used to evaluate their effectiveness in prediction of OS. Ten radiomics features and thirty gene expression levels showed significant differences between ER and non-ER groups. Two radiomics features (LLH_GLCM_corrm, LHH_GLSZM_SZLGE) and four genomics features (DFFA, LOC101060524, chr9: 67183179-67219393, CT45A8) were optimally selected to build the radiomics and genomics signatures separately, whose individual values in predicting 1-year ER equal to an AUC of 0.717 and 0.808, respectively. The radiogenomics model constructed showed an improved predictive value with an AUC of 0.832. Furthermore, the radiomics signature showed no significant value in prediction of OS. Instead, both the genomics signature alone and the radiogenomics model showed a significant predictive capability for OS. A radiogenomics model integrating CT radiomics signature with gene characteristics was established to improve the prediction accuracy of ER and OS in patients with EC, which would direct towards integrative system-based approaches with prognostic implications for personalized RT.

CT-based radiomics combined with hematologic parameters for survival prediction in locally advanced esophageal cancer patients receiving definitive chemoradiotherapy

CT-based radiomics for predicting radio-chemotherapy response and overall survival in nonsurgical esophageal carcinoma

CT-based deep learning radiomics and hematological biomarkers in the assessment of pathological complete response to neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma: A two-center study

CT radiomics features of meso-esophageal fat in predicting overall survival of patients with locally advanced esophageal squamous cell carcinoma treated by definitive chemoradiotherapy

A 18F-FDG PET/CT-based Deep Learning-Radiomics-clinical Model for Prediction of Cervical Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma

Dual-region radiomics signature: Integrating primary tumor and lymph node computed tomography features improves survival prediction in esophageal squamous cell cancer

Predictive and prognostic markers from endoscopic ultrasound with biopsies during definitive chemoradiation therapy in esophageal squamous cell carcinoma

Integrating 18F-FDG PET/CT radiomics and body composition for enhanced prognostic assessment in patients with esophageal cancer

Computed Tomography-Based Radiomics Nomogram for Predicting the Postoperative Prognosis of Esophageal Squamous Cell Carcinoma: A Multicenter Study

Prognostic and Incremental Value of Computed Tomography-Based Radiomics from Tumor and Nodal Regions in Esophageal Squamous Cell Carcinoma

The role of spleen radiomics model for predicting prognosis in esophageal squamous cell carcinoma patients receiving definitive radiotherapy

Post-radiation circulating tumor DNA as a prognostic factor in locally advanced esophageal squamous cell carcinoma

Positron Emission Tomography-Based Radiomics Features May Be Prognostic Of Outcome In Patients With Esophageal Squamous Cell Carcinoma Treated With Chemoradiation Therapy

A Radiogenomics Framework To Improve Prediction Of Clinical Outcomes In Patients With Esophageal Cancer Treated With Concurrent Chemoradiotherapy

CT Radiomics to Predict Pathologic Complete Response after Neoadjuvant Immunotherapy Plus Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma

The Prognostic Value of Positron Emission Tomography/computed Tomography-Based Parameters in Locally Advanced Esophageal Squamous Cell Carcinoma Treated with Chemoradiation Therapy

A Deep Learning Radiomics Analysis for Survival Prediction in Esophageal Cancer

Radiomics nomogram combined with clinical factors for predicting pathological complete response in resectable esophageal squamous cell carcinoma

A Radiomics Nomogram for Non-Invasive Prediction of Progression-Free Survival in Esophageal Squamous Cell Carcinoma

Predictive role of ctDNA in esophageal squamous cell carcinoma receiving definitive chemoradiotherapy combined with toripalimab

A nomogram based on pretreatment radiomics and dosiomics features for predicting overall survival associated with esophageal squamous cell cancer